|
RBM39 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.918300E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.250200E-02 |
| Normal-vs-Stage2 |
2.868600E-01 |
| Normal-vs-Stage3 |
4.875400E-01 |
| Normal-vs-Stage4 |
6.646000E-01 |
| Stage1-vs-Stage2 |
8.723800E-01 |
| Stage1-vs-Stage3 |
4.168800E-01 |
| Stage1-vs-Stage4 |
5.025200E-01 |
| Stage2-vs-Stage3 |
6.506600E-01 |
| Stage2-vs-Stage4 |
6.346000E-01 |
| Stage3-vs-Stage4 |
8.905400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.521600E-03 |
| Normal-vs-AfricanAmerican |
6.558300E-02 |
| Normal-vs-Asian |
3.266200E-01 |
| Caucasian-vs-AfricanAmerican |
5.504800E-01 |
| Caucasian-vs-Asian |
8.257600E-01 |
| AfricanAmerican-vs-Asian |
9.833400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.059300E-03 |
| Normal-vs-Female |
1.991800E-02 |
| Male-vs-Female |
9.225600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.312410E-01 |
| Normal-vs-Extreme_Weight |
1.026160E-01 |
| Normal-vs-Obese |
1.751750E-02 |
| Normal-vs-Extreme_Obese |
5.332400E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.651400E-01 |
| Normal_Weight-vs-Obese |
5.415000E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.637600E-01 |
| Extreme_Weight-vs-Obese |
3.617800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.221800E-01 |
| Obese-vs-Extreme_Obese |
4.184000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.284000E-03 |
| Normal-vs-Age(41-60Yrs) |
6.634500E-04 |
| Normal-vs-Age(61-80Yrs) |
7.132200E-02 |
| Normal-vs-Age(81-100Yrs) |
2.006600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.543800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.335200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.763100E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.348300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.132260E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.995950E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.000920E-04 |
| Normal-VS-Type2 PRCC |
1.966030E-01 |
| Normal-VS-KIRP CIMP |
7.755200E-01 |
| Normal-VS-Unclassified PRCC |
2.803800E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.44139997107595E-09 |
| Type1 PRCC-VS-KIRP CIMP |
1.455620E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.628200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.987000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.717400E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
1.212440E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.880400E-01 |
| Normal-vs-N1 |
8.556400E-02 |
| Normal-vs-N2 |
5.123000E-01 |
| N0-vs-N1 |
8.126100E-02 |
| N0-vs-N2 |
5.317200E-01 |
| N1-vs-N2 |
2.607200E-01 |
|
|
